Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States

Gynecologic Oncology

Volumn 108, Issue 3, 2008, Pages 577-583

  Stroup, A M ^a   Harlan, L C ^b   Trimble, E L ^b  

^a UNIVERSITY OF UTAH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; Patterns of care; Treatment; Vulva; Vulvar

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; TAXANE DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; PATIENT CARE; PRIORITY JOURNAL; TREATMENT OUTCOME; VULVA CANCER; VULVECTOMY;

EID: 39249084652     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.11.011     Document Type: Article

References (27)

1. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov). SEER*Stat Database: Incidence-SEER 17 Regs Public-Use, Nov 2005 Sub (1973-2003 varying)-Linked To County Attributes-Total U.S., 1969-2003 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on the November 2005 submission.
2. American Cancer Society. Cancer Facts & Figures (2007), American Cancer Society, Atlanta
3. Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Horner MJ, Howlader N, Eisner MP, Reichman M, Edwards BK, editors. SEER Cancer Statistics Review, 1975-2004, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2004/, based on November 2006 SEER data submission, posted to the SEER web site, 2007.
4. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov). SEER*Stat Database: Incidence-SEER 13 Regs Public-Use, Nov 2005 Sub (1992-2003)-Linked To County Attributes-Total U.S., 1969-2003 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on the November 2005 submission.
5. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov). SEER*Stat Database: Mortality-All COD, Public-Use With State, Total U.S. (1969-2003), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006. Underlying mortality data provided by NCHS (www.cdc.gov/nchs).
6. Canavan TP, Cohen D. Vulvar cancer. Am Fam Physician 2002;66:1269-74,1276.
7. Madeleine M.M., Daling J.R., Carter J.J., Wipf G.C., Schwartz S.M., McKnight B., et al. Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst 89 (1997) 1516-1523
8. Benedet J.L., Bender H., Jones III H., Ngan H.Y., and Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70 2 (Aug 2000) 209-262
9. Gotlieb W.H. The assessment and surgical management of early-stage vulvar cancer. Best Pract Res Clin Obstet Gynaecol 17 4 (Aug 2003) 557-569
10. Kim RY, Alvarez RD, Omura GA. Advances in the treatment of gynecologic malignancies: Part 1. Cancers of the cervix and vulva. Oncology (Williston Park). 2002 Nov;16(11):1510-7, 1521; discussion 1522-4, 1528, 1530. Review.
11. de Hullu J.A., van der Avoort I.A., Oonk M.H., et al. Management of vulvar cancers. Eur J Surg Oncol 32 (2006) 825-831
12. In: Hoskins W.J., Perez C.A., and Young R.C. (Eds). Principles and Practices of Gynecologic Oncology. 2nd ed. (1996), Lippincott Williams and Wilkins, Philadelphia, PA
13. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 5 (1987) 373-383
14. Shah B.V., Barnwall B.G., and Bieler G.S. SUDAAN (1997), Research Triangle Institute, Research Triangle Park, NC
15. Homesley H.D. Management of vulvar cancer. Cancer 76 10 Suppl (Nov 15 1995) 2159-2170
16. Stehman F.B., and Look K.Y. Carcinoma of the vulva. Obstet Gynecol 107 3 (Mar 2006) 719-733
17. Berek J.S., Heaps J.M., Fu Y.S., Juillard G.J., and Hacker N.F. Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva. Gynecol Oncol 42 3 (Sep 1991) 197-201
18. Moore D.H., Thomas G.M., Montana G.S., Saxer A., Gallup D.G., and Olt G. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys 42 1 (Aug 1 1998) 79-85
19. Tombolini V., Raffetto N., Santarelli M., Valeriani M., Necozione S., Madedu F., et al. Carcinoma of the vulva: clinical results of exclusive and adjuvant radiotherapy. Anticancer Res 25 4 (Jul-Aug 2005) 3089-3094
20. Harlan L.C., Clegg L.X., and Trimble E.L. Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J Clin Oncol 21 (2003) 3488-3494
21. Harlan L.C., Abrams J., Warren J., Clegg L., Stevens J., and Ballard-Barbash R. Adjuvant therapy for breast cancer-practice patterns of community physicians. JCO 20 (2002) 1809-1817
22. National Cancer Institute, Vulvar cancer PDQ: treatment http://www.cancer.gov/cancertopics/pdq/treatment/vulvar/HealthProfessional/page4.
23. Rouzier R., Haddad B., Atallah D., Dubois P., and Paniel B.J. Surgery for vulvar cancer. Clin Obstet Gynecol 48 4 (2005) 869-878
24. Weikel W., Hofmann M., Steiner E., Knapstein P.G., and Koelbl H. Reconstructive surgery following resection of primary vulvar cancers. Gynecol Oncol 99 (2005) 92-100
25. Green M.S., Naumann R.W., Elliot M., et al. Sexual dysfunction following vulvectomy. Gynecol Oncol 77 (2000) 73-77
26. de Hullu J.A., Hollema H., Lolkema S., Boezen M., Bonstra H., Burger M.P., et al. Vulvar carcinoma: the price of less radical surgery. Cancer 95 (2002) 2331-2338
27. Kosary C.L. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol 10 1 (Jan-Feb 1994) 31-46